...
首页> 外文期刊>The American Journal of the Medical Sciences >Correlation of epidermal growth factor receptor with morphological features of colorectal advanced adenomas: a pilot correlative case series.
【24h】

Correlation of epidermal growth factor receptor with morphological features of colorectal advanced adenomas: a pilot correlative case series.

机译:表皮生长因子受体与大肠晚期腺瘤形态特征的相关性:一个试验性相关病例系列。

获取原文
获取原文并翻译 | 示例

摘要

INTRODUCTION: The epidermal growth factor receptor (EGFR) pathway is important to colorectal carcinogenesis. Although EGFR is described to be overexpressed in adenomas, to the authors' knowledge, its relationship with advanced features in adenomas and as a marker for adenoma progression has not been studied. METHODS: Initially, 13 polyps (sizes 3 mm-5.5 cm) from a 63-year-old patient were stained for EGFR. Subsequently, a validation group of 95 adenomas from 16 patients were graded semiquantitatively for EGFR staining. Size and villous features of the adenomas were evaluated by 2 independent pathologists and compared with EGFR expression. To be classified as advanced, adenomas needed to be greater than 1 cm and fulfill 1 of the 2 criteria-villous component >20% to 25% or presence of high-grade dysplasia. RESULTS: In the index case, the large 5.5 cm tubulovillous adenoma had EGFR positivity in all of its neoplastic cells, whereas another 2 cm tubular adenoma with focal villous features had 30% EGFR positivity. All other polyps and normal colonic mucosa were negative for EGFR. In 95 adenomas from 16 additional patients, there was a significant correlation of EGFR positivity with adenoma size >/=1 cm and villous features (all P < 0.001). The odds of EGFR expression in advanced adenomas were 17.3 times higher than nonadvanced adenomas (P < 0.001). CONCLUSIONS: These findings suggest that EGFR overexpression is associated with advanced colorectal adenomas. Further larger studies are needed to explore EGFR expression as a biomarker for adenoma progression.
机译:简介:表皮生长因子受体(EGFR)通路对于结直肠癌的发生至关重要。尽管据描述EGFR在腺瘤中过表达,但据作者所知,尚未研究其与腺瘤中晚期特征的关系以及作为腺瘤进展的标志物。方法:最初,对一名63岁患者的13例息肉(大小3 mm-5.5 cm)进行EGFR染色。随后,对来自16位患者的95个腺瘤的验证组进行了EGFR染色的半定量分级。由两名独立的病理学家评估腺瘤的大小和绒毛特征,并与EGFR表达进行比较。要被分类为晚期,腺瘤必须大于1 cm并满足2个标准中的1个-轻度成分> 20%至25%或存在高度不典型增生。结果:在索引病例中,大的5.5 cm肾小管腺瘤在其所有肿瘤细胞中均具有EGFR阳性,而另外2 cm具有局灶性绒毛特征的肾小管腺瘤EGFR阳性。所有其他息肉和正常结肠粘膜的EGFR阴性。在另外16名患者的95个腺瘤中,EGFR阳性与腺瘤大小> / = 1 cm和绒毛状特征显着相关(所有P <0.001)。 EGFR在晚期腺瘤中表达的几率是非晚期腺瘤的17.3倍(P <0.001)。结论:这些发现提示EGFR的过表达与晚期结直肠腺瘤有关。需要进一步的更大研究来探索EGFR表达作为腺瘤进展的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号